TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,440 | -42.7% | 16,964 | -41.8% | 0.06% | -39.6% |
| Q2 2023 | $457,912 | -6.4% | 29,148 | -1.8% | 0.10% | -4.0% |
| Q1 2023 | $489,386 | +74729.7% | 29,696 | -29.2% | 0.10% | -28.6% |
| Q4 2022 | $654 | -99.7% | 41,915 | +113.2% | 0.14% | +122.2% |
| Q3 2022 | $255,000 | -47.1% | 19,656 | -42.7% | 0.06% | -45.2% |
| Q2 2022 | $482,000 | +15.6% | 34,321 | +17.8% | 0.12% | +9.5% |
| Q1 2022 | $417,000 | +64.2% | 29,142 | +56.3% | 0.10% | +64.1% |
| Q4 2021 | $254,000 | -3.4% | 18,646 | +16.2% | 0.06% | -13.5% |
| Q3 2021 | $263,000 | +13.9% | 16,041 | +17.1% | 0.07% | +15.6% |
| Q2 2021 | $231,000 | +1.8% | 13,704 | +10.4% | 0.06% | -3.0% |
| Q1 2021 | $227,000 | – | 12,410 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
| Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
| Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
| Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
| TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
| Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
| BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
| Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |